Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Adiponectin (Arcp30, AdipoQ, apM1, or GBP28), a novel 247-amino acid peptide, is secreted predominantly by adipocytes and accounts for ∼0.05% of total serum proteins (1)(2)(3)(4). It is induced early in adipocyte differentiation (1), consists of an N-terminal collagenous and a C-terminal globular domain, and shares homology to subunits of complement factor C1q (1)(3). Adiponectin expression is reduced in obesity and type 2 diabetes, and plasma concentrations of adiponectin are inversely related to body weight and insulin concentrations (5)(6)(7)(8). Treatment with adiponectin improves insulin sensitivity in mouse models of insulin resistance (9)(10), and in adiponectin knockout mice, adiponectin substitution can reverse diet-induced insulin resistance (11). Adiponectin is also inversely associated with other traditional cardiovascular risk factors, such as blood pressure, heart rate, total cholesterol, LDL-cholesterol, and triglycerides (12)(13). In addition, recent studies suggest that it may have antiatherogenic and antiinflammatory properties (14)(15)(16)(17)(18)(19). Adiponectin may therefore be an important blood biomarker to assess in large-scale epidemiologic studies of several chronic diseases. To gain a reliable risk estimate with a single blood measurement, the within-person variability over time should be small compared with the between-person variability (20). In addition, the stability of a valid biological marker should not be substantially affected by length of storage or temperature (21)(22)(23)(24)(25). Ideally, serum or plasma from whole blood should be separated immediately and stored in deep freeze. In large epidemiologic studies, however, blood specimens are often collected at different times and locations and transported on ice over several hours or days to central laboratories for processing and storage. The aims of the present study were to evaluate the stability of human adiponectin concentrations in blood specimens collected and stored on ice packs for up to 36 h before processing and to assess the reproducibility of human adiponectin concentrations over a period of 1 year. The stability of adiponectin was assessed from samples collected in EDTA (6 male and 6 female volunteers) and sodium-heparin (12 female volunteers) Vacutainers, both after a 12-h overnight fast. The samples were collected in three 10-mL Vacutainers and stored with ice packs in Styrofoam containers. This process emulated the conditions we used to collect more than 60 000 blood samples mailed to our laboratory from cohort members of the Health Professionals Follow-up Study (HPFS), the Nurses’ Health Study, and the Nurses’ Health Study II (25). Time to process was defined as 0, 24, and 36 h after venipuncture. Samples were centrifuged and aliquoted for storage in liquid nitrogen (−150 °C) at each of the three time points. Each sample was assigned a different identification number and was randomly placed in the analysis batch with respect to the three different processing time periods. In a separate pilot study we randomly selected 300 men from the HPFS and collected two EDTA samples 1 year apart, using methods described elsewhere (25). From this pilot collection, we chose a subsample of 20 men to test the 1-year reproducibility of adiponectin. Similar to the stability study, each sample was assigned a different identification number and was randomly placed in the analysis batch with respect to the date of blood collection. In the main HPFS, information about health and disease status is assessed biennially by a self-administered questionnaire, starting in 1986 (26). All participants gave written informed consent, and the study was approved by the Harvard School of Public Health Human Subjects Committee Review Board. Plasma adiponectin was measured by competitive RIA using a commercial reagent set (Linco Research Inc.), utilizing a highly purified antibody raised against recombinant human adiponectin. The samples were analyzed in duplicate, with one reagent set each for the EDTA stability samples, the sodium-heparin stability samples, and the EDTA reproducibility samples. We included additional samples to assess the intraassay variation and found CVs of 16% (n = 4) for the EDTA stability samples, 26% (n = 6) for the sodium-heparin stability samples, and 20% (n = 2) for the reproducibility samples. Adiponectin values were ln-transformed to improve the normality of the distribution and are presented as geometric means and 95% confidence intervals (CIs). The Student paired t-test of geometric means was used to compare the adiponectin concentrations measured at different time-to-process periods and to compare the concentrations in 2000 and 2001. Intraclass correlation coefficients were calculated by ANOVA to assess the stability of adiponectin over time and to assess the reproducibility from the year 2000 to 2001 (20). To account for changes in body weight over time, we adjusted our reproducibility analysis for body mas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Prospective study of alcohol consumption and risk of coronary disease in men.
Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B., & Stampfer, M. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90542-w · Cited by 1,239
Self-citation
Cited by
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Self-citationMeier, U., & Gressner, A. M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032482 · Cited by 1,035
Adiponectin: mechanistic insights and clinical implications
Turer, A. T., & Scherer, P. E. (2012) · Diabetologia · doi:10.1007/s00125-012-2598-x · Cited by 632
Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
Wei, E. K., Giovannucci, E., Fuchs, C. S., Willett, W. C., & Mantzoros, C. S. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji376 · Cited by 492
Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A. M., Danesh, J., & Whincup, P. H. (2006) · Circulation · doi:10.1161/circulationaha.106.618918 · Cited by 403
Metadata
- Authors
- Pischon, T., Hotamisligil, G. S., & Rimm, E. B.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 49
- Issue
- 4
- Pages
- 650-652
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2080430240
- Cited by
- 147
- References
- 5
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.